What happened
Original notice title
FDA Issues Warning About Certain Supplements Substituted with Toxic Yellow Oleander
From the archived source record
The FDA has added one additional product containing toxic yellow oleander to this Safety Alert. The complete list of products can be found in the chart below. The agency is reminding consumers to avoid these products because they have been tested and found to contain toxic yellow oleander and can cause neurologic, gastrointestinal and cardiovascular adverse health effects that may be severe, or even fatal. FDA analysis has determined that certain products labeled as tejocote ( Crataegus mexicana ) root or Brazil seed are adulterated because they contain yellow oleander ( Thevetia peruviana ) instead of the labeled ingredients. Yellow oleander is a poisonous plant native to Mexico and Central America and a toxic substance of concern to public health officials. Consumers can also contact the state poison control center . ALIPOTEC Tejocote Root Dietary Supplement Pieces Nutraholics ELV Tejocote Root Dietary Supplement Pieces In September 2023, the Centers for Disease Control and Prevention published a report of several tejocote root products found to be substituted with yellow oleander, a toxic substance. Based on this report, the FDA initiated an investigation to sample and test additional tejocote root products. As part of FDA’s ongoing surveillance sampling efforts, we continue to test products; those found to contain yellow oleander are listed above. Based on the FDA’s sampling and testing results thus far, the FDA is also concerned that other products marketed as tejocote root (including with other names such as Crataegus mexicana , Raiz de Tejocote, and Mexican Hawthorn) may contain yellow oleander. Consuming yellow oleander can cause severe adverse health effects and be potentially fatal. The FDA’s investigation is ongoing, and the FDA will continue to provide information on any further actions as it becomes available. Products may be added to this advisory. The FDA is working to further address the concerns related to these products and monitoring the market for adverse events, product complaints, and other emerging issues.
What the official notice says to do
Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice →Status and source details
- Status recorded in the archive
- Published FDA communication
- Source checked
- Jul 16, 2026
- Record revision
- 2bc58553fcf1
This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage →